Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | SATKARTAR Sat Kartar Shopping Ltd. Pharma · SME | BAFNAPH Bafna Pharmaceuticals Limited Pharma · Small | AMANTA Amanta Healthcare Limited Pharma · Small | HALEOSLABS HALEOS LABS LIMITED Pharma · Small |
|---|---|---|---|---|
| Final Score | 69 | 24 | 44 | 29 |
| Verdict | UNDERVALUED | OVERVALUED | WATCHLIST | OVERVALUED |
| Style | Growth at Value | OVERVALUED | WATCHLIST | OVERVALUED |
| Piotroski | 6/9 | 2/9 | 6/9 | 8/9 |
| Valuation | 17/30 | 5/30 | 9/30 | 7/30 |
| Growth | 23/25 | 9/25 | 21/25 | 8/25 |
| Quality | 17/20 | 0/20 | 0/20 | 0/20 |
| Balance Sheet | 12/15 | 11/15 | 7/15 | 9/15 |
| Cash Flow | 0/10 | 3/10 | 4/10 | 3/10 |
| Price | ₹160.2 | ₹174.58 | ₹135.46 | ₹1,407.9 |
| P/E | 15.30 | — | 31.80 | 23.70 |
| P/B | 3.87 | 0.90 | 2.38 | 1.92 |
| ROE | 28.70% | -6.18% | 10.40% | 8.44% |
| ROCE | 37.30% | -3.00% | 11.60% | 9.91% |
| Debt / Equity | 0.03 | 0.06 | 1.11 | 0.52 |
| FCF Yield | — | — | — | — |
| Dividend Y | 0.42% | — | — | 0.11% |
| Altman Z | 10.48 | 7.86 | 2.40 | 2.91 |
| Promoter % | 63.62% | 75.00% | 63.72% | 72.10% |
| Mkt Cap (₹Cr) | 261.00 | 459.00 | 523.00 | 410.00 |
| Graham # | ₹102.38 | — | ₹69.9 | ₹953.72 |
| Fair PE | 42.0 | 42.0 | 42.0 | 13.8 |
| MoS % | +64.9% | — | +15.8% | -77.9% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startSATKARTAR99
BAFNAPH212
AMANTA97
HALEOSLABS101